Treatment and outcome of biopsy-proven fulminant myocarditis in adults

被引:11
作者
Chau, EMC [1 ]
Chow, WH
Chlu, CSW
Wang, E
机构
[1] Grantham Hosp, Dept Cardiol, Aberdeen, Hong Kong, Peoples R China
[2] Grantham Hosp, Dept Cardiothorac Surg, Hong Kong, Hong Kong, Peoples R China
[3] Grantham Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
fulminant myocarditis; endomyocardial biopsy; immunosuppression; mechanical circulatory support; GLOBULIN; TRIAL;
D O I
10.1016/j.ijcard.2005.07.082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fulminant myocarditis may be rapidly fatal with severe haemodynamic compromise in previously healthy patients. We reviewed our experience with eight cases of biopsy-proven fulminant myocarditis (seven cases with lymphocytic myocarditis and one with eosinophilic myocarditis). Immunosuppression was given in seven out of eight cases. Mechanical circulatory support was required in 50% of the patients. Time from onset of illness to recovery of ventricular function varied from 12 to 17 days. All except one patient were alive at a mean follow-up of 4.4 years after the acute illness. Patients with acute fulminant myocarditis should be treated aggressively with immunosuppression and, if necessary, mechanical circulatory support during the first 2 to 3 weeks of the illness because of the reversible nature of this illness and good long-term prognosis. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:405 / 406
页数:2
相关论文
共 6 条
[1]  
Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3
[2]   GAMMA-GLOBULIN TREATMENT OF ACUTE MYOCARDITIS IN THE PEDIATRIC POPULATION [J].
DRUCKER, NA ;
COLAN, SD ;
LEWIS, AB ;
BEISER, AS ;
WESSEL, DL ;
TAKAHASHI, M ;
BAKER, AL ;
PEREZATAYDE, AR ;
NEWBURGER, JW .
CIRCULATION, 1994, 89 (01) :252-257
[3]  
Galiuto L, 1997, MAYO CLIN PROC, V72, P603
[4]   A CLINICAL-TRIAL OF IMMUNOSUPPRESSIVE THERAPY FOR MYOCARDITIS [J].
MASON, JW ;
OCONNELL, JB ;
HERSKOWITZ, A ;
ROSE, NR ;
MCMANUS, BM ;
BILLINGHAM, ME ;
MOON, TE ;
COSTANZO, MR ;
GRADY, K ;
KANTROWITZ, NE ;
ZELDIS, SM ;
KANE, S ;
COGLIANESE, ME ;
TOMEO, C ;
BACON, K ;
MCLAUGHLIN, PR ;
LIU, P ;
ROSS, B ;
PALACIOS, IF ;
DEC, W ;
BLOCK, B ;
COCCASPOFFARD, D ;
YOUNG, JB ;
LEON, C ;
CASTA, R ;
KINGRY, C ;
STRICKMAN, NE ;
HARLAN, M ;
FOWLER, N ;
ENGEL, P ;
NUNN, N ;
DAS, SK ;
SUHY, P ;
KLINE, E ;
GILLES, AJ ;
FRENCH, WJ ;
SKINNER, A ;
UNVERFERTH, DV ;
SARLING, R ;
NEWTON, P ;
WOODINGSCOTT, M ;
UNTEREKER, WJ ;
POLL, D ;
HOFFMAN, K ;
FRANK, J ;
FOWLES, R ;
MILLAR, K ;
FREEDMAN, L ;
LYVER, S ;
LATHAM, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :269-275
[5]   Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. [J].
McCarthy, RE ;
Boehmer, JP ;
Hruban, RH ;
Hutchins, GM ;
Kasper, EK ;
Hare, JM ;
Baughman, KL .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (10) :690-695
[6]  
McNamara DM, 2001, CIRCULATION, V103, P2254